Download PDF
Thromb Haemost 1983; 50(04): 792-796
DOI: 10.1055/s-0038-1665314
Original Article
Schattauer GmbH Stuttgart

Intra-Coronary Thrombolysis with Streptokinase or Lys-Plasminogen/Urokinase in Acute Myocardial Infarction: Effects on Recanalization and Blood Fibrinolysis

D de Prost
1   The Service d’Hématologie et d’immunologie Biologiques, Université Paris 7, Paris, France
,
C Guerot
2   The Service de Cardiologie, C. H. U. Xavier Bichat, Université Paris 7, Paris, France
,
N Laffay
2   The Service de Cardiologie, C. H. U. Xavier Bichat, Université Paris 7, Paris, France
,
M H Horellou
3   The Laboratoire Central d’Hématologie, C. H. U. Broussais, Hôtel Dieu, Université Paris 6, Paris, France
,
M Samama
3   The Laboratoire Central d’Hématologie, C. H. U. Broussais, Hôtel Dieu, Université Paris 6, Paris, France
› Author Affiliations
Further Information

Publication History

Received 17 June 1983

Accepted 17 August 1983

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Forty-two patients with total occlusion of a coronary vessel were treated with intracoronary fibrinolytic agents. Four therapeutic protocols were compared: group I received streptokinase (SK) as a continuous infusion; group II and III received SK as a bolus at different doses and group IV received lysplasminogen (Pg) plus urokinase (UK); maximal doses were 350,000 IU of SK and 250,000 IU of UK plus 75 μK of Pg. Thrombolysis was assessed by coronary angiography. Coagulation studies were performed prior to, 15 min and 6 hr after the end of the thrombolytic treatment. Recanalization was achieved in 27 of the 31 SK-treated patients (87%) and in 7 of the 11 Pg-UK- treated patients (63.6%). The recanalization frequency was the same in the three SK-treated groups, even though when SK was administered as a bolus, the dose was significantly less than when administered on a continuous infusion. Although systemic fibrinolysis occurred in all 4 groups of patients, this effect was less pronounced in the UK-treated patients than in the three SK- treated groups. This study also shows that recanalization can be achieved with a dose of SK lower than the anti-SK antibody level. Haemorrhagic side effects were minimal in all patients studied. Severe defibrination is usually considered a risk of haemorrhage. These preliminary results suggest that bolus injection of SK or the use of UK plus lys-Pg can reduce the level of defibrination and thus the haemorrhagic risk.

Keywords

Myocardial infarction - Systemic fibrinolysis - Local thrombolysis - streptokinase - Urokinase - Lys-plasminogen
 

  • References

  • 1 Merx W, Dörr R, Rentrop P, Blanke H, Karsch KR, Mathey DG, Kremer P, Rutsch W, Schmutzler H. Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: postprocedure management and hospital course in 204 patients. Am Heart J 1981; 102: 1181-1187
    CrossrefPubMedGoogle Scholar
  • 2 Timmis GC, Gangadharan V, Hauser AM, Ramos RG, Westveer DC, Gordon S. Intracoronary streptokinase in clinical practice. Am Heart J 1982; 104: 925-938
    CrossrefPubMedGoogle Scholar
  • 3 Weinstein J. Treatment of myocardial infarction with intracoronary streptokinase: efficacy and safety data from 209 United States cases in the Hoechst-Roussel registry. Am Heart J 1982; 104: 894-898
    CrossrefPubMedGoogle Scholar
  • 4 Sharma GV R k, Cella G, Parisi AF, Sasahara AA. Thrombolytic therapy. N Engl J Med 1982; 306: 1268-1276
    CrossrefPubMedGoogle Scholar
  • 5 Kötering H, Rentrop P, Kaiser H, Blanke J, Ganasinsky J, Tebbe U, Neuhaus KL. Effect of intracoronary streptokinase-infusion on blood coagulation and fibrinolysis in patients with acute myocardial infarction. Haemostasis 1982; 11 (suppl) (Suppl. 01) 145 (Abstr.)
    PubMedGoogle Scholar
  • 6 Rentrop P, Blanke H, Karsch KR, Wiegand V, Köstering H, Oster H, Leitz K. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2: 354-363
    CrossrefPubMedGoogle Scholar
  • 7 Cowley MJ, Hastillo A, Vetrovec GW, Hess ML. Effects of intracoronary streptokinase in acute myocardial infarction. Am Heart J 1981; 102: 1149-1158
    CrossrefPubMedGoogle Scholar
  • 8 Fisher LMc A, Garret R, Cowley MJ, Hastillo A, Vetrovec GW. Alterations in blood coagulation associated with low dose intra-coronary infusion of streptokinase in acute myocardial infarction. Haemostasis 1982; 11 (suppl) (Suppl. 01) 80 (Abstr.)
    PubMedGoogle Scholar
  • 9 Rutsch W, Schartl M, Mathey D, Kuck K, Merx W, Dörr R, Rentrop P, Blanke H. Percutaneous transluminal coronary recanalization: procedure, results and acute complications. Am Heart J 1981; 102: 1178-1181
    CrossrefPubMedGoogle Scholar
  • 10 Cowley MJ, Hastillo A, Vetrovec GW, Fisher LM, Garret R, Hess ML. Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency. Circulation 1983; 67: 1031-1038
    CrossrefPubMedGoogle Scholar
  • 11 Cernigliaro C, Sansa M, Campi A, Bongo A S, Rossi P. Intracoronary thrombolysis with urokinase in acute myocardial infarction: effects on reperfusion and left ventricular wall motion. In: Fibrinolytic Therapy. Tröbestein G, Etzel F. Schattauer; Stuttgart - New York: 1983. pp 521-526
    Google Scholar
  • 12 Nobuyoshi M, Nosaka H, Nishimura K. Coronary spasm and throm-bosis in acute myocardial infarction. Circulation 1982; 66 (suppl II) (Suppl. 02) 353 (Abstr.)
    PubMedGoogle Scholar
  • 13 Tennant S, Campbell WB, Dixon J, Page H, Roach A, Kaiser A. Intracoronary thrombolysis in acute myocardial infarction: compari-son of efficacy of urokinase to streptokinase. Circulation 1982; 66 (suppl II) (Suppl. 02) 1346 (Abstr.)
    PubMedGoogle Scholar
  • 14 Biggs RM. Human blood coagulation, haemostasis and thrombosis. Blackwell Scientific Publications; Oxford: 1972
    Google Scholar
  • 15 Von Clauss A. Gerinnungsphysiologische Schnell-Methode zur Be-stimmung des Fibrinogens. Acta Haematol (Basel) 1957; 17: 237-246
    CrossrefPubMedGoogle Scholar
  • 16 Milstone H. Factor in normal blood which participates in streptococcal fibrinolysis. J Immunol 1941; 42: 109-116
    PubMedGoogle Scholar
  • 17 Soria J, Soria C, Samama M. A plasminogen assay using a chromogenic synthetic substrate. Results from clinical work and from studies of thrombolysis. Progress in chemical fibrinolysis and thrombolysis pp 337-346 Raven Press; New York: 1978
    Google Scholar
  • 18 Juhan I, Calas MF, Buonocore M, Matthieu P, Isnard G, Cazenave B, Serradimigni A. Modifications in coagulation parameters induced by treatment associating urokinase (2000 U CTA/kg/h) with heparin. Thromb Haemostas 1979; 42: 945-954
    PubMedGoogle Scholar